1,581 Shares in Thermo Fisher Scientific Inc (TMO) Acquired by Intl Fcstone Inc.

Intl Fcstone Inc. purchased a new position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,581 shares of the medical research company’s stock, valued at approximately $276,000.

Other hedge funds also recently modified their holdings of the company. Proficio Capital Partners LLC increased its position in Thermo Fisher Scientific by 71.5% during the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock worth $105,000 after purchasing an additional 253 shares during the last quarter. Cribstone Capital Management LLC increased its position in shares of Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock worth $109,000 after acquiring an additional 50 shares in the last quarter. Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific in the second quarter worth $113,000. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the second quarter worth $108,000. Finally, CWM LLC increased its position in shares of Thermo Fisher Scientific by 17.0% in the second quarter. CWM LLC now owns 710 shares of the medical research company’s stock worth $124,000 after acquiring an additional 103 shares in the last quarter. 83.78% of the stock is owned by hedge funds and other institutional investors.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 1,000 shares of the firm’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the transaction, the director now directly owns 38,757 shares in the company, valued at $6,790,226.40. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Jim P. Manzi sold 11,318 shares of the firm’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the transaction, the director now owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,738 shares of company stock valued at $4,021,512. Corporate insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was first published by Markets Daily and is owned by of Markets Daily. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.themarketsdaily.com/2017/11/13/1581-shares-in-thermo-fisher-scientific-inc-tmo-acquired-by-intl-fcstone-inc.html.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at $186.18 on Monday. The company has a market cap of $74,657.32, a PE ratio of 20.46, a price-to-earnings-growth ratio of 1.71 and a beta of 1.08. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.81 and a current ratio of 1.26. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The business’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.03 EPS. equities research analysts forecast that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Shareholders of record on Friday, December 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is 10.19%.

Several brokerages have recently weighed in on TMO. Jefferies Group LLC restated a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Finally, Morgan Stanley restated an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Thermo Fisher Scientific currently has a consensus rating of “Buy” and a consensus target price of $205.71.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply